The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome: A Prospective, Controlled Study in 254 Affected Women
Open accessAbstract
Women with polycystic ovary syndrome (PCOS) are insulin resistant, have insulin secretory defects, and are at high risk for glucose intolerance. We performed this study to determine the prevalence of glucose intolerance and parameters associated with risk for this in PCOS women. Two-hundred and fifty-four PCOS women, aged 14-44 yr, were prospectively evaluated at 2 centers, 1 urban and ethnically diverse (n = 110) and 1 rural and ethnically homogeneous (n = 144). The rural PCOS women were compared to 80 control women of similar weight, ethnicity, and age. A 75-g oral glucose challenge was administered after a 3-day 300-g carbohydrate diet and an overnight fast with 0 and 2 h blood samples for glucose levels. Diabetes was categorized according to WHO criteria. The prevalence of glucose intolerance was 31.1% impaired glucose intolerance (IGT) and 7.5% diabetes. In nonobese PCOS women (body mass index, <27 kg/m2), 10.3% IGT and 1.5% diabetes were found. The prevalence of glucose intolerance was significantly higher in PCOS vs. control women (chi2 = 7.0; P = 0.01; odds ratio = 2.76; 95% confidence interval = 1.23-6.57). Variables most associated with postchallenge glucose levels were fasting glucose levels (P < 0.0001), PCOS status (P = 0.002), waist/hip ratio (P = 0.01), and body mass index (P = 0.021). The American Diabetes Association criteria applied to fasting glucose significantly underdiagnosed diabetes compared to the WHO criteria (3.2% vs. 7.5%; chi2 = 4.7; P = 0.046; odds ratio = 2.48; 95% confidence interval = 1.01-6.69). We conclude that 1) PCOS women are at significantly increased risk for IGT and type 2 diabetes mellitus at all weights and at a young age; 2) these prevalence rates are similar in 2 different populations of PCOS women, suggesting that PCOS may be a more important risk factor than ethnicity or race for glucose intolerance in young women; and 3) the American Diabetes Association diabetes diagnostic criteria failed to detect a significant number of PCOS women with diabetes by postchallenge glucose values.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As such, women with PCOS exhibit increased risk of impaired glucose tolerance and T2DM regardless of weight and age [20].”
From Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis (2019) · cites this paper as [20]
In the citing paper
“Approximately 50–70% of women with PCOS have IR and hyperinsulinaemia [128], whereas many also present evidence of glucose intolerance [20].”
From Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis (2019) · cites this paper as [20]
In the citing paper
“In women with PCOS, dysglycemia typically consists of impaired glucose tolerance [12], its prevalence being of almost 30% in both adult women [13] and affected adolescents [14].”
From From Prediabetes to Type 2 Diabetes Mellitus in Women with Polycystic Ovary Syndrome: Lifestyle and Pharmacological Management (2020) · cites this paper as [12]
In the citing paper
“PCOS patients commonly have metabolic complications, such as type 2 diabetes, insulin resistance (IR), and adipose tissue dysfunction (7–9).”
From Circulating Adipokine Levels in Nonobese Women with Polycystic Ovary Syndrome and in Nonobese Control Women: A Systematic Review and Meta-Analysis (2021) · cites this paper as [7]
In the citing paper
“However, women with PCOS generally have hyperandrogenism and lower SHBG [52] and differences at the end of the intervention are again likely related to baseline differences.”
From Weight management interventions in women with and without PCOS: a systematic review (2017) · cites this paper as [52]
In the citing paper
“However, women with PCOS generally have hyperandrogenism and lower SHBG [52] and differences at the end of the intervention are again likely related to baseline differences.”
From Weight management interventions in women with and without PCOS: a systematic review (2017) · cites this paper as [52]
In the citing paper
“In PCOS, other novel CVD risk factors, premature cardiovascular dysfunction and subclinical CVD 29,30,83 have been noted and are related to IR and obesity. 84-89”
From Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline (2011) · cites this paper as [85]
Citations
Cites
The publisher hasn’t deposited this paper’s reference list.
Cited by
Sorted by citations
Items 701–800 of 1,388
Association of CAPN10 SNPs and Haplotypes with Polycystic Ovary Syndrome among South Indian Women
Dasgupta, S., Sirisha, P. V. S., Neelaveni, K., Katragadda, A., & Reddy, B. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032192 · Cited by 35
Pamuk, B. Ö., Torun, A. N., Kulaksızoğlu, M., Ertuğrul, D. T., Çiftçi, Ö., Kulaksızoğlu, S., Yıldırım, E., & Demirağ, N. G. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.10.073 · Cited by 35
Chang, W., Goodarzi, M. O., Williams, H., Magoffin, D. A., Pall, M., & Azziz, R. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.10.025 · Cited by 35
Bedaiwy, M. A., Abdel-Rahman, M., Tan, J., AbdelHafez, F. F., Abdelkareem, A. O., Henry, D., Lisonkova, S., Hurd, W. W., & LIU, J. H. (2018) · Journal of Women s Health · doi:10.1089/jwh.2017.6584 · Cited by 35
Rachmiel, M., Kives, S. L., Atenafu, E. G., & Hamilton, J. (2008) · PubMed · doi:10.1001/archpedi.162.6.521 · Cited by 35
Targeting insulin sensitivity in the treatment of polycystic ovary syndrome
Pasquali, R., & Gambineri, A. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903190699 · Cited by 35
Charnvises, K., Weerakiet, S., Tingthanatikul, Y., Wansumrith, S., Chanprasertyothin, S., & Rojanasakul, A. (2005) · Gynecological Endocrinology · doi:10.1080/09513590500216776 · Cited by 35
Kulshreshtha, B., Ganie, M. A., Praveen, E. P., Gupta, N., Khurana, M. L., Seith, A., Dwivedi, S. N., Kumar, G., & Ammini, A. C. (2008) · Gynecological Endocrinology · doi:10.1080/09513590802342858 · Cited by 35
Childhood obesity: a growing public health concern
Must, A., Hollander, S. A., & Economos, C. D. (2006) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.1.2.233 · Cited by 35
Spironolactone for Hirsutism in Polycystic Ovary Syndrome
Christy, N. A., Franks, A. S., & Cross, L. B. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1g025 · Cited by 35
Suitability of recommended limits for fasting glucose tests in women with polycystic ovary syndrome
Gagnon, C., & Baillargeon, J.-P. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.060607 · Cited by 33
Varlamov, O., Bishop, C. V., Handu, M., Takahashi, D., Srinivasan, S., White, A., & Roberts, C. T. (2017) · Human Reproduction · doi:10.1093/humrep/dex244 · Cited by 34
Luque‐Ramírez, M., Alpañés, M., & Escobar-Morreale, H. F. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.11.049 · Cited by 34
Amato, M. C., Magistro, A., Gambino, G., Vesco, R., & Giordano, C. S. D. S. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0600 · Cited by 34
Endothelial maintenance in health and disease: Importance of sex differences
Mudrovcic, N., Arefin, S., Craenenbroeck, A. H. V., & Kublickiene, K. R. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.01.011 · Cited by 34
Carmina, E., Nasrallah, M., Guastella, E., & Løbo, R. A. (2019) · Clinical Endocrinology · doi:10.1111/cen.14063 · Cited by 34
Polycystic ovarian syndrome – prognosis and treatment outcomes
Hart, R. J. (2007) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e3282f10e22 · Cited by 34
Diamanti‐Kandarakis, E., & Economou, F. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1367.006 · Cited by 35
Huang, S., Qiao, J., Li, R., Wang, L., & Li, M. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.03.005 · Cited by 34
Safar, F. H., Mojiminiyi, O. A., Al‐Rumaih, H., & Diejomaoh, M. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.152025 · Cited by 34
Tsai, Y.-H., Wang, T.-W., Wei, H.-J., Hsu, C.-Y., Ho, H.-J., Chen, W.-H., Young, R., Liaw, C.-M., & Chao, J. C.-J. (2013) · British Journal of Nutrition · doi:10.1017/s0007114512004369 · Cited by 34
Ganie, M. A., Hassan, S., Nisar, S., Shamas, N., Rashid, A., Ahmed, I., Douhat, S., Mudassar, S., Jan, V. M., & Rashid, F. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.924099 · Cited by 34
Xie, Y., Xiao, L. Y., & Li, S. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.701590 · Cited by 35
Demirci, H., Yılmaz, M., Ergün, M. A., Yurtçu, E., Bukan, N. C., & Ayvaz, G. (2009) · Gynecological Endocrinology · doi:10.3109/09513590903367051 · Cited by 34
Polycystic Ovaries and Polycystic Ovary Syndrome in Epilepsy: Evidence for Neurogonadal Disease
Harden, C. L. (2005) · Epiliepsy currents/Epilepsy currents · doi:10.1111/j.1535-7511.2005.00039.x · Cited by 34
Oral, B., Ceyhan, B. M., Dilek, M., Alanoğlu, G., & Sütçü, R. (2009) · Gynecological Endocrinology · doi:10.1080/09513590802549874 · Cited by 34
Möhlig, M., Flöter, A., Spranger, J., Weickert, M. O., Schill, T., Schlößer, H. W., Brabant, G. E., Pfeiffer, A. F. H., Selbig, J., & Schöfl, C. (2006) · Diabetologia · doi:10.1007/s00125-006-0395-0 · Cited by 34
Relationship between the characteristic traits of polycystic ovary syndrome and susceptibility genes
Hong, S.-H., Hong, Y. S., Jeong, K., Chung, H., Lee, H., & Sung, Y.-A. (2020) · Scientific Reports · doi:10.1038/s41598-020-66633-2 · Cited by 32
Jamilian, M., Sabzevar, N. K., & Asemi, Z. (2018) · Hormone and Metabolic Research · doi:10.1055/a-0749-6431 · Cited by 33
Ortiz-Flores, A. E., Luque‐Ramírez, M., Fernández‐Durán, E., Álvarez‐Blasco, F., & Escobar-Morreale, H. F. (2019) · Metabolism · doi:10.1016/j.metabol.2019.01.015 · Cited by 33
Reproductive factors, metabolic factors, and coronary artery calcification in older women
Atsma, F., Bartelink, M.-L. E. L., Grobbee, D. E., Rutten, A., Bots, M. L., Prokop, M., & van der Schouw, Y. T. (2008) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181653d7d · Cited by 33
Polycystic Ovary Syndrome in Adolescents
O'Brien, R. F., & Emans, S. J. (2008) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2007.07.007 · Cited by 32
Traditional Persian Medicine and management of metabolic dysfunction in polycystic ovary syndrome
Hosseinkhani, A., Asadi, N., Pasalar, M., & Zarshenas, M. M. (2017) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2017.04.006 · Cited by 33
Use of Insulin-Sensitizing Agents in Patients With Polycystic Ovary Syndrome
Bloomgarden, Z. T., Futterweit, W., & Poretsky, L. (2001) · Endocrine Practice · doi:10.4158/ep.7.4.279 · Cited by 33
BERRIA, R., GASTALDELLI, A., LUCIDI, S., BELFORT, R., DEFILIPPIS, E., EASTON, C., BRYTZKI, R., CUSI, K., JOVANOVIC, L., & DEFRONZO, R. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.03.014 · Cited by 33
Divalent cations in women with PCOS: implications for cardiovascular disease
Muneyyirci‐Delale, O., Nacharaju, V. L., Dalloul, M., Jalou, S., Rahman, M., Altura, B. M., & Altura, B. T. (2001) · Gynecological Endocrinology · doi:10.1080/gye.15.3.198.201 · Cited by 33
Bhattacharya, S. M. (2009) · Gynecological Endocrinology · doi:10.3109/09513590903367010 · Cited by 33
Diamanti‐Kandarakis, E., Alexandraki, K., Bergiele, A. T., KANDARAKIS, H. A., Mastorakos, G. P., & Aessopos, A. (2004) · Journal of Endocrinological Investigation · doi:10.1007/bf03347535 · Cited by 33
Irgam, K., Reddy, B. M., Annamaneni, S., & Rayabarapu, P. (2019) · Gene · doi:10.1016/j.gene.2019.03.042 · Cited by 31
Zhai, H., Wu, H., Xu, H., Weng, P., Xia, F., Chen, Y., & Lu, Y. (2012) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-10-5 · Cited by 31
Shanaki, M., Moradi, N., Fadaei, R., Zandieh, Z., Shabani, P., & Vatannejad, A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208059 · Cited by 31
Thiruppathi, M., Dhevika, S., Palaniappan, M., & Balasubramanian, K. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.06.009 · Cited by 32
Effects of metformin use in pregnant patients with polycystic ovary syndrome
Kumar, P., & Khan, K. (2012) · Journal of Human Reproductive Sciences · doi:10.4103/0974-1208.101012 · Cited by 33
Rees, E., Coulson, R.-M. K., Dunstan, F., Evans, W. D., Blundell, H. L., Luzio, S. D., Dunseath, G. J., Halcox, J., Fraser, A. G., & Rees, A. (2014) · Human Reproduction · doi:10.1093/humrep/deu180 · Cited by 32
Kelly, C., & Booth, G. L. (2004) · BMC Women s Health · doi:10.1186/1472-6874-4-s1-s16 · Cited by 32
Ibáñez, L., Aulesa, C., Potau, N., Ong, K. K., Dunger, D. B., & de Zegher, F. (2002) · Pediatric Research · doi:10.1203/00006450-200202000-00019 · Cited by 31
A 27-Year-Old Woman With a Diagnosis of Polycystic Ovary Syndrome
Legro, R. S. (2007) · JAMA · doi:10.1001/jama.297.5.509 · Cited by 33
Self-citationThe time has come to simplify the evaluation of the hirsute patient
Azziz, R. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(00)01526-0 · Cited by 32
Soares, N. P., Santos, A. C. S. D., Costa, E. C., Azevedo, G. D., Damasceno, D. C., Fayh, A. P. T., & Lemos, T. M. A. M. (2016) · Annals of Nutrition and Metabolism · doi:10.1159/000444130 · Cited by 31
Ezeh, U. I., Pisarska, M. D., & Azziz, R. (2022) · Human Reproduction · doi:10.1093/humrep/deac001 · Cited by 31
Wei, H., Young, R., Kuo, I.-L., Liaw, C., Chiang, H., & Yeh, C. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.02.168 · Cited by 31
Su, C.-L., CHEN, M., Huang, H., & Lin, J.-F. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3401 · Cited by 32
Zargar, A. H., Gupta, V., Wani, A. I., Masoodi, S. R., Bashir, M. I., Laway, B. A., Ganie, M. A., & Salahuddin, M. (2005) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-3-35 · Cited by 31
Elkind-Hirsch, K. E., Paterson, M. S., Seidemann, E. L., & Gutowski, H. C. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.09.023 · Cited by 34
Risk of Cardiovascular Events in Mothers of Women with Polycystic Ovary Syndrome
Cheang, K. I., Nestler, J. E., & Futterweit, W. (2008) · Endocrine Practice · doi:10.4158/ep.14.9.1084 · Cited by 31
The long term health consequences of polycystic ovary syndrome
Kelly, C. J., Connell, J., Cameron, I. T., Gould, G. W., & Lyall, H. (2000) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2000.tb11644.x · Cited by 29
Jing, Z., Xu, L., Tai-xiang, W., Tang, Y., & Jia, Y.-J. (2008) · Gynecological Endocrinology · doi:10.1080/09513590802288242 · Cited by 31
Kodaman, P. H., & Dulęba, A. J. (2008) · Drugs · doi:10.2165/00003495-200868130-00001 · Cited by 31
Vrbíková, J., Stanická, S., Dvorakova, K., Hill, M., Vondra, K., Bendlová, B., & Stárka, L. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500215 · Cited by 31
Chiu, W.-L., Boyle, J. A., Vincent, A. J., Teede, H. J., & Moran, L. (2016) · Neuroendocrinology · doi:10.1159/000455233 · Cited by 31
Wang, F., Pan, J., Wu, Y. T., Zhu, Y., Hardiman, P. J., & Qu, F. (2018) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1700074 · Cited by 31
Garmes, H. M., Tambascia, M. A., & Zantut‐Wittmann, D. E. (2005) · Gynecological Endocrinology · doi:10.1080/09513590500430575 · Cited by 31
Heinonen, S., Korhonen, S., Helisalmi, S., Koivunen, R., Tapanainen, J., HippelÄInen, M., & Laakso, M. (2005) · Gynecological Endocrinology · doi:10.1080/09513590500238796 · Cited by 30
Ewens, K. G., Jones, M. R., Ankener, W., Stewart, D. R., Urbanek, M., Dunaif, A. E., Legro, R. S., Chua, A. K., Azziz, R., Spielman, R. S., et al. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.02.050 · Cited by 30
Self-citationGanie, M. A., Dhingra, A., Nisar, S., Sreenivas, V., Shah, Z. A., Rashid, A., Masoodi, S. R., & Gupta, N. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.09.005 · Cited by 30
Tan, M. H., Alquraini, H., Mizokami‐Stout, K., & MacEachern, M. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.06.008 · Cited by 33
Nonalcoholic fatty liver disease and obstructive sleep apnea in women with polycystic ovary syndrome
Doycheva, I., & Ehrmann, D. A. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.03.020 · Cited by 33
Wongwananuruk, T., Rattanachaiyanont, M., Indhavivadhana, S., Leerasiri, P., Techatraisak, K., Tanmahasamut, P., Angsuwathana, S., & Dangrat, C. (2012) · International Journal of Endocrinology · doi:10.1155/2012/529184 · Cited by 30
Hoang, V., Bi, J., MohanKumar, S. M. J., & Vyas, A. K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126119 · Cited by 30
Sir‐Petermann, T., Bárbara Angel, B., Maliqueo, M. A., Santos, J. L., Riesco, M. D., Toloza, H., & Pérez‐Bravo, F. (2004) · Nutrition · doi:10.1016/j.nut.2004.08.017 · Cited by 30
Natural Remedies for Polycystic Ovarian Syndrome (PCOS) : A Review
Goswami, P. K., Khale, A., & Ogale, S. (2012) · Cited by 30
Polycystic Ovary Syndrome in Adolescents
Witchel, S. F., Roumimper, H., & Oberfield, S. E. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.01.004 · Cited by 32
Type 2 Diabetes in Children and Youth
KAUFMAN, F. R. (2003) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/a:1021871302554 · Cited by 30
Pirotta, S., Joham, A., Grieger, J. A., Tay, C. T., Bahri-Khomami, M., Lujan, M., Lim, S. S., & Moran, L. J. (2020) · Seminars in Reproductive Medicine · doi:10.1055/s-0041-1726866 · Cited by 29
Silva, R. D. C., Pardini, D., & Kater, C. E. (2006) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302006000200014 · Cited by 35
Saturated fatty acid exposure induces androgen overproduction in bovine adrenal cells
Bellanger, S., Battista, M., Fink, G. D., & Baillargeon, J. (2012) · Steroids · doi:10.1016/j.steroids.2011.12.017 · Cited by 27
Aye, M. M., Kilpatrick, E. S., Aburima, A. A., Wraith, K. S., Magwenzi, S., Spurgeon, B. E. J., Rigby, A. S., Sandeman, D. D., Naseem, K. M., & Atkin, S. L. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000706 · Cited by 29
Lazaridou, S., Dinas, K., & Tziomalos, K. (2017) · HORMONES · doi:10.14310/horm.2002.1757 · Cited by 27
Öktem, M., Özçimen, E. E., Üçkuyu, A., Esinler, İ., Pamuk, B. Ö., Bayraktar, N., Kulaksızoğlu, S., & Zeyneloğlu, H. B. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.03.039 · Cited by 29
Roldan, M. B., White, C., & Witchel, S. F. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.11.126 · Cited by 29
Metformin and intervention in polycystic ovary syndrome
Norman, R. J., Kidson, W., Cuneo, R. C., Zacharin, M., & Endocrine Society of Australia, T. A. D. S. A. T. A. P. E. G. (2001) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2001.tb143439.x · Cited by 29
Polycystic ovary syndrome – Phenotypes and diagnosis
Christakou, C. D., & Diamanti‐Kandarakis, E. (2014) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2014.936675 · Cited by 29
Suri, J., Suri, J. C., Chatterjee, B., Mittal, P., & Adhikari, T. (2016) · Sleep Medicine · doi:10.1016/j.sleep.2016.02.014 · Cited by 28
Wei, D., Zhang, B., Shi, Y., Zhang, L., Zhao, S., Du, Y., Xu, L., Legro, R. S., Zhang, H., & Chen, Z. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01294 · Cited by 29
Self-citationLee, E.-J., Oh, B., Lee, J., Kimm, K., Park, J.-M., & Baek, K. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.06.049 · Cited by 28
CD4+CD28null T lymphocytes are expanded in young women with polycystic ovary syndrome
Niccoli, G., Apa, R., Lanzone, A., Liuzzo, G., Spaziani, C., Sagnella, F., Cosentino, N., Moro, F., Martínez, D., Morciano, A., et al. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.01.129 · Cited by 28
Seow, K., Tsai, Y.-L., Hwang, J.-L., Hsu, W.-Y., Ho, L. T., & Juan, C. (2009) · Human Reproduction · doi:10.1093/humrep/dep122 · Cited by 28
Futterweit, W. (2007) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2007.07.004 · Cited by 28
Fraser, I. S., & Kovacs, G. (2004) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2004.06.009 · Cited by 40
Polycystic Ovary Syndrome in Adolescence
Baumann, E. E., & Rosenfield, R. L. (2002) · The Endocrinologist · doi:10.1097/00019616-200207000-00011 · Cited by 28
Lewis, V. (2001) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70182-0 · Cited by 29
Velija-Ašimi, Z., Bureković, A., Dujić, T., Dizdarević-Bostandžić, A., & Semiz, S. (2016) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2016.1428 · Cited by 26
Andrisse, S., Billings, K., Xue, P., & Wu, S. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00195.2017 · Cited by 28
Valsamakis, G., Lois, K., Kumar, S., & Mastorakos, G. P. (2013) · HORMONES · doi:10.1007/bf03401302 · Cited by 28
Ehrmann, D. A., Breda, E., Corcoran, M. H., Cavaghan, M. K., Imperial, J., TOFFOLO, G. M., Cobelli, C., & Polonsky, K. S. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00475.2003 · Cited by 28
Sex Steroid Hormones and Reproductive Disorders
Fauser, B. C. J. M., Laven, J. S. E., Tarlatzis, B. C., Moley, K. H., Critchley, H., Taylor, R. N., Berga, S. L., Mermelstein, P. G., Devroey, P., Gianaroli, L., et al. (2011) · Reproductive Sciences · doi:10.1177/1933719111405068 · Cited by 30
Primary Prevention of Atherosclerotic Cardiovascular Disease in Women
McKibben, R. A., Rifai, M. A., Mathews, L. M., & Michos, E. D. (2015) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-015-0480-3 · Cited by 29
Wiltgen, D., Furtado, L. B. F. D. S., Kohek, M. B. D. F., & Spritzer, P. M. (2007) · Gynecological Endocrinology · doi:10.1080/09513590701233661 · Cited by 28
Topçu, S., Çalışkan, M., Özçimen, E. E., Tok, D., Üçkuyu, A., Erdoğan, D., Güllü, H., Yı́ldı́rı́r, A., Zeyneloğlu, H. B., & Müderrisoğlu, H. (2005) · Human Reproduction · doi:10.1093/humrep/dei431 · Cited by 28
tRNA Biology in the Pathogenesis of Diabetes: Role of Genetic and Environmental Factors
Arroyo, M. N., Green, J. A., Cnop, M., & Igoillo‐Esteve, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020496 · Cited by 27
Metadata
- Authors
- Legro, R. S.
- Affiliations
- Pennsylvania State University (US)
- ORCID
- Legro, R. S.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1999-01-01
- Volume
- 84
- Issue
- 1
- Pages
- 165-169
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2096126402
- Cited by
- 1,743
- References
- 0
- Citations by year
- 2026: 16 · 2025: 25 · 2024: 36 · 2023: 24 · 2022: 50 · 2021: 64 · 2020: 54 · 2019: 42 · 2018: 43 · 2017: 66 · 2016: 59 · 2015: 88 · 2014: 81 · 2013: 73 · 2012: 84
- FWCI
- 44.44
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by)
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK040605)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (K08 HD-O118, U54HD034449)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Keywords
- polycystic ovary syndrome, type 2 diabetes, impaired glucose tolerance, insulin resistance, insulin secretion, diabetes risk factors, prevalence, fasting blood glucose, waist-to-hip ratio, body mass index, ethnic differences, diagnostic criteria, underdiagnosis, oral glucose tolerance test, young women, obesity
- MeSH terms
- Adolescent, Adult, Blood Glucose, Diabetes Mellitus, Type 2, Female, Glucose Tolerance Test, Humans, Insulin Resistance, Polycystic Ovary Syndrome, Prospective Studies, Risk, Body Mass Index, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
